Fundraising Fox

ArriVent BioPharma

NASDAQ: AVBP

Newtown Square, US · Founded 2021 · Delaware corporation · 7 known investors

Clinical-stage biopharmaceutical company focused on identifying, developing and commercializing differentiated medicines for cancer patients.

BiotechMedical Devices

Founders & leadership

BR
Brent RiceChief Commercial Officer
JZ
Jason ZhangDirector
CX
Cong XuDirector
Z(
Zhengbin (Bing) YaoExecutive Officer, Director
SL
Stuart LutzkerDirector

Investors · 7

Catalio Capital Management, LPNew York
General CatalystSan Francisco · $30M
HongShanHong Kong · $100K – $50M
LAVHong Kong · $5M – $15M
Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
OrbiMedNew York · $1M – $75M
Sofinnova VenturesreportedMenlo Park · $100K – $15M

Reported raises · per SEC filings

Form D private placements
▶$110MraisedDec 2022 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stuart LutzkerDirector
  • James HealyDirector
  • Carl GordonDirector
  • Jason ZhangDirector
  • Zhengbin (Bing) YaoExecutive Officer, Director
  • Bahija JallalDirector
  • Cong XuDirector
Offering amount
$145M
Amount sold
$110M
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150MraisedFeb 2022 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason ZhangDirector
  • Cong XuDirector
  • Zhengbin (Bing) YaoExecutive Officer, Director
  • Stuart LutzkerDirector
Offering amount
$150M
Amount sold
$150M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news